Highlights from Pharmap 2024

29 May 2024

PHARMAP 2024 Сongress, held in Amsterdam on 22-23 April 2024, brought together 300+ leading minds in the pharmaceutical industry for two days of thought-provoking discussions and insights. This year’s event focused on the most pressing challenges and groundbreaking solutions shaping the future of pharma manufacturing and packaging.

Industry Leaders Unite

PHARMAP 2024 was proud to partner with industry majors and local Dutch companies like MSD, Johnson & Johnson Innovative Medicine, Organon, Echo Pharmaceuticals B.V., Produlab Pharma, and Media partner PHARMACEUTICAL SUPPLY CHAIN INITIATIVE. These partnerships fostered a dynamic environment for collaboration and knowledge exchange.

We are incredibly grateful to DOHMEYER, our Principal Sponsor, for their invaluable contribution to PHARMAP 2024. Fabian Van Damme, Director at DOHMEYER, delivered a thought-provoking welcome speech during the Executive Opening Panel. He later teamed up with Kyle Koning, Cold Chain Innovation Principal Engineer at Accenture, for a captivating Leaders Panel discussion with the topic “Back to the Ice Age: Cryogenics’ Crucial Role in mRNA Production for Next-Gen Therapies.”

A Deep Dive into Packaging Quality and Regulatory Landscape

New session format, thought-provoking Leader’s Talk by Andrea Zoppi (Global Quality Systems – Packaging & Labelling – Associate Director at Eli Lilly) captivated the audience at PHARMAP 2024. Zoppi’s presentation, titled “Packaging quality: relationship with authoritative rules and harmonising differences in QRM for drug product and devices,” delved into the critical interplay between packaging quality and regulatory requirements.

Sustainability Takes Center Stage

PHARMAP 2024 recognised the growing importance of sustainability in the pharmaceutical industry. A dedicated roundtable discussion, “Advancing Sustainability in the Pharmaceutical Industry,” featured thought leaders like Jürgen Bodenmüller (Director of Business Development at SÜDPACK Medica AG), Brett Marshall (Vice President – Quality & HSSE at Zuellig Pharma), Vitor Antunes (Regional Sales Director at Romaco), and Megi Erpardo(Sustainability Manager at Abdi İbrahim Pharmaceuticals). These experts explored various strategies for creating a more sustainable future for pharma, from adopting eco-friendly packaging solutions to optimising manufacturing processes.

Optimising Pharmaceutical Manufacturing Processes

Session 5 on “Pharmaceutical manufacturing process optimisation” showcased advancements in this critical area. Experts from Shimadzu Europa GmbH, Emerson, Zuellig Pharma and ARANOW INTERNATIONAL discussed innovative techniques such as Process Analytical Technology (PAT), flow health diagnostics, and automation solutions for microdosing and packaging.

Evolving Facility Design for the Future

The “Tomorrow’s Hub: Evolution in Facility Design” roundtable discussion explored the latest trends in pharmaceutical facility design. Jens Engstrand (Regional Business Development Manager TM Flooring EMEA at Sika Services AG – Corporate Construction), Hichem Chougui (Business Development manager at SPA PHARMA INVEST PRODUCTION), Mehdi Chehili (CEO at SPA PHARMA INVEST PRODUCTION), Maurice Janssen (Sr. specialist Real estate, Facility Management & Sustainability at Organon), and Eric Monrabal (Product Engineer at Getinge) shared their insights on cutting-edge approaches to designing and constructing pharmaceutical facilities that are not only efficient and compliant but also future-proof.

Interactive Engagement

A unique highlight of the Congress was the interactive activity by Bayer during one of the sessions, where attendees used a QR code to vote on the most pressing issues currently facing the industry. This valuable data will be compiled by Bayer to gain crucial insights.

Looking Ahead: PHARMAP 2025 in Berlin

PHARMAP 2025 will be held in Berlinon 14-15 April 2025, marking the congress’s fifth anniversary. Preparations for this landmark event are already underway, promising even more insightful discussions and groundbreaking revelations for the pharmaceutical industry.  

PHARMAP team: “We extend our sincere gratitude to all participants who came to share their knowledge and experiences. We look forward to welcoming the community back to the next edition of the Congress”. 

Learn more: PHARMAP 2025